SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-005412
Filing Date
2018-05-15
Accepted
2018-05-15 16:01:05
Documents
39
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT gtbp_10q.htm 10-Q 459049
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF gtbp_311.htm EX-31.1 18116
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF gtbp_312.htm EX-31.2 18420
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE gtbp_321.htm EX-32.1 9504
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE gtbp_322.htm EX-32.1 9151
  Complete submission text file 0001654954-18-005412.txt   1703716

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gtbp-20180331.xml EX-101.INS 169186
7 XBRL TAXONOMY EXTENSION SCHEMA gtbp-20180331.xsd EX-101.SCH 21366
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gtbp-20180331_cal.xml EX-101.CAL 31715
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gtbp-20180331_def.xml EX-101.DEF 58768
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gtbp-20180331_lab.xml EX-101.LAB 140169
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gtbp-20180331_pre.xml EX-101.PRE 113375
Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602
Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 18836152
SIC: 2834 Pharmaceutical Preparations